# FDA Inspection 1026192 - ImpactLife - July 18, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/impactlife/a78a55a8-8e4d-4695-8d0d-bd3e9d3b1521/
Source feed: FDA_Inspections

> FDA Inspection 1026192 for ImpactLife on July 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026192
- Company Name: ImpactLife
- Inspection Date: 2017-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1274630 - 2025-07-03](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/8f57693f-a1d8-4fed-9d81-69de6e1fbea1/)
- [FDA Inspection 1274630 - 2025-07-03](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/70b8fff0-40b4-4b48-9483-174dd05fa22b/)
- [FDA Inspection 1106877 - 2019-09-12](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/b159f44b-ff95-4cc4-9d5b-467f195cb29f/)
- [FDA Inspection 1026192 - 2017-07-18](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/730e4c6b-4cea-48ef-bfa8-2ba874235d8a/)
- [FDA Inspection 921394 - 2015-03-26](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/653ca604-c2ca-47c5-88a3-c28f6698bdc1/)

Company: https://www.globalkeysolutions.net/companies/impactlife/4a069fdf-ff53-49b2-b830-1f43d195d28e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d